APOA1 and ovarian cancer: As shown in Figure 4A,B, the treatment with 50 or 100 μg/mL of ApoA1 mimetic peptide was able to prevent ovarian cancer cell invasion, as the number of cells that invaded the Matrigel and reached the bottom compartment of the plate was significantly lower comparatively to untreated cells (Kruskal–Wallis with Dunn’s post-test; control: 105.5 [93.8–119.8]; 50 μg/mL treatment: 29 [12–60.2]; control vs. 50 μg/mL treatment: p = 0.0020; 100 μg/mL treatment: 30 [13–61]; control vs. 100 μg/mL treatment: p = 0.0016).